Search clinical trials for: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone

Total 446 results

Ewha Womans University
Chonbuk National University Hospital; Chonnam National University Hospital; Seoul... and other collaborators

Unknown

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1 (BEST-IgAN-1)

Glomerulonephritis, Immunoglobulin A (IgA)
Hanmi Pharmaceutical Company Limited
Seoul National University Bundang Hospital

Completed

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Hypertension(HTN)

Korea, Republic of
Second Xiangya Hospital of Central South University
Baxter Healthcare Corporation

Unknown

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Chronic Renal Disease

China
Massachusetts General Hospital

Recruiting

Losartan in Prevention of Radiation-Induced Heart Failure

Myocardial Fibrosis | Breast Cancer | Radiation-Induced Fibrosis

United States
Armed Forces Post Graduate Medical Institute (AFPGMI)...

Recruiting

Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial

Vascular Access Complication

Pakistan
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
University of Pavia

Unknown

Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

Hypertension

Italy
Organon and Co

Completed

ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

High Blood Pressure
Odense University Hospital
University of Southern Denmark; Lundbeck Foundation; Else Poulsen Mindelegat

Unknown

Prevention of Decompensation in Liver Cirrhosis

Ascites | Alcoholic Liver Cirrhosis

Denmark
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
Steadman Philippon Research Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

Osteoarthritis, Knee

United States
Pharmtechnology LLC
Reliance Life Sciences Private Limited

Completed

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Healthy

India
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada
H. Lee Moffitt Cancer Center and Research Institute
Novartis Pharmaceuticals

Recruiting

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA

Myelodysplastic Syndromes

United States
Hennepin Healthcare Research Institute

Completed

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial (LIFE-HIV)

Fibrosis | Inflammation

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

Hypertension
Pamukkale University
Gazi University

Completed

Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment

Hypertension

Turkey
University of Cambridge
British Heart Foundation

Unknown

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension (Pathway 1)

Essential Hypertension | Hypertension, Resistant to Conventional Therapy

United Kingdom
Novartis

Completed

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Hypertension

United States
Steadman Philippon Research Institute
United States Department of Defense; Office of Naval Research (ONR)

Terminated

Losartan to Improve Hip Microfracture

Fibrosis | Hip Osteoarthritis | Cartilage Damage | Hip Impingement Syndrome

United States
Organon and Co

Completed

LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

Hypertension
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Chronic Kidney Disease

Korea, Republic of
Mansoura University

Completed

The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

Uropathy | Losartan Adverse Reaction | Uropathy Obstructive

Egypt
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University

Completed

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study (FELINE)

Nonalcoholic Steatohepatitis

United Kingdom
Assaf-Harofeh Medical Center

Unknown

Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

Hypertension
Miriam Vos, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children...

Completed

Study of Losartan in the Treatment of NAFLD in Children

NAFLD

United States
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Completed

A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients

Hyperglycemia | Hypertension | Obesity

United States
Boryung Pharmaceutical Co., Ltd
Chonbuk National University Hospital; Samsung Medical Center; Asan Medical Center and other collaborators

Completed

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Hypertension
Ain Shams University

Recruiting

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Colorectal Cancer | Chemotherapy | Oral Mucositis | Intestinal Mucositis

Egypt
Novartis

Completed

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Hypertension

India
Organon and Co

Completed

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

Mild to Severe Hypertension
Amorepacific Corporation

Completed

Anti-pollution Effects of AP Green Tea Extracts

Respiratory Conditions Due to Unspecified External Agent

Korea, Republic of
Medical University of Gdansk

Completed

Influence of Aliskiren on Albuminuria After Kidney Transplantation

Albuminuria

Poland
Daiichi Sankyo, Inc.
Shanghai Sankyo Pharmaceuticals Co., Ltd.

Completed

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

China
Yonsei University

Completed

Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

Essential Hypertension

Korea, Republic of
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
Children's Hospital Medical Center, Cincinnati

Completed

Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

Eosinophilic Esophagitis | Connective Tissue Disorders

United States
Medical University of Graz

Completed

Telmisartan and Losartan in Hypertensive IGT

Hypertension | Impaired Glucose Tolerance

Austria
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Anna Stanhewicz, PhD

Active, not recruiting

Sex Differences in the Dilatory Response of Compound 21

Sex Differences

United States
Laboratorios Silanes S.A. de C.V.

Completed

Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

Essential Arterial Hypertension

Mexico
Yangzhou University

Completed

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Depression

China
Jiangsu Province Hospital of Traditional Chinese...
Ministry of Science and Technology of the People´s Republic of China; The First... and other collaborators

Unknown

Chinese Medicine Treat for Hypertensive Renal Injury (CHAIR)

Hypertension | Renal Injury
Organon and Co

Terminated

An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

Hypertension
Alicia Gerke
Pulmonary Fibrosis Foundation

Terminated

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis

United States
Novartis Pharmaceuticals

Completed

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling (ALLMARK)

Hypertension | Left Ventricle Hypertrophy

Spain
Daiichi Sankyo, Inc.
Daiichi Sankyo Taiwan Ltd.

Completed

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Essential Hypertension

Taiwan
Chinese Academy of Medical Sciences, Fuwai Hospital
National Natural Science Foundation of China

Recruiting

Effect of Gut Microbiome Restoration on Primary Hypertension Via Dietary Intervention

Hypertension

China
Massachusetts General Hospital

Completed

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

United States

Search clinical trials for: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations